サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1310547

分子品質管理の世界市場：製品タイプ別、用途別、検体タイプ別、エンドユーザー別、地域別 - 予測（～2028年）

Molecular Quality Controls Market Product (Independent Control, Instrument Specific Control ), Application (Infectious Disease Diagnostics), Analyte type, End User (Hospitals, Diagnostic Lab), Region- Global Forecast to 2028
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 282 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
分子品質管理の世界市場：製品タイプ別、用途別、検体タイプ別、エンドユーザー別、地域別 - 予測（～2028年）
出版日: 2023年07月13日
発行: MarketsandMarkets
ページ情報: 英文 282 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の分子品質管理の市場規模は、2023年の2億米ドルから2028年までに3億米ドルに達し、予測期間中にCAGRで6.6%の成長が予測されています。

市場の成長は主に、ゲノムプロジェクトに対する政府の資金提供の増加や、個別化医療に対する需要の増加、シーケンシング処置のコストの低下、感染症、がん、遺伝性疾患の流行によって促進されています。しかし、品質管理プロセスに伴う追加のコストや、病院と研究所における予算の制約、分子検査に対する不利な償還シナリオが、予測期間中に市場成長を抑制することが見込まれる主な要因となっています。

独立管理セグメントが予測期間中に市場で最大のシェアを占める見込みです。

製品別では、市場は独立管理と器具固有管理に区分されます。2022年の世界の分子品質管理市場では、独立管理セグメントが最大のシェアを占めています。サードパーティの独立管理の利用の増加が、このセグメントの大きなシェアの要因となっています。

単一検体管理が予測期間中に市場で最大のシェアを占める見込みです。

検体の種類別では、市場は単一検体管理と複数検体管理に区分されます。単一検体管理は、2022年の分子品質管理市場で最大のシェアを占めました。病院におけるシングルプレックスアッセイの顕著な利用や、低い交差反応性のリスクなどが、このセグメントの大きなシェアの要因です。

感染症診断セグメントが2022年に市場で最大のシェアを占めました。

用途別では、市場は感染症診断、遺伝子検査、腫瘍検査、その他の用途（神経疾患検査、DNAフィンガープリンティング、組織タイピング、微生物学、心血管疾患検査を含む）に区分されます。感染症診断セグメントは、2022年の世界の分子品質管理市場で最大のシェアを占めました。感染症の有病率の大幅な増加が、このセグメントの大きなシェアの要因となっています。

診断研究所セグメントは2022年に市場で最大のシェアを占めました。

エンドユーザー別では、市場は学術・研究機関、診断研究所、IVDメーカー・CRO、病院、その他のエンドユーザー（在宅医療機関、血液銀行、ナーシングホーム、地域の公衆衛生研究所）に区分されます。診断研究所セグメントが2022年に分子品質管理市場で最大のシェアを占めました。診断研究所で実施される臨床検査数の増加が、このセグメントの大きなシェアの要因となっています。

北米が2022年の分子品質管理市場で最大のシェアを占めました。

地域別では、市場は北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカに区分されます。北米は2022年に分子品質管理市場を独占しました。この地域セグメントが大きなシェアを占めているのは、主に米国とカナダで医療システムが発達していることや、分子品質管理製品の主要メーカーが多数存在すること、北米で先進技術製品が容易に利用できることなどに起因します。

当レポートでは、世界の分子品質管理市場について調査分析し、市場力学、地域とセグメントの分析、企業プロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 主要考察

  • 分子品質管理市場の概要
  • 分子品質管理市場：製品別
  • アジア太平洋、分子品質管理市場：用途別、国別
  • 分子品質管理市場：地理的ミックス
  • 分子品質管理市場：先進国市場 vs. 新興国市場

第5章 市場の概要

  • イントロダクション
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 業界の動向
  • 価格分析
  • バリューチェーン分析
  • サプライチェーン分析
  • エコシステム分析
  • ポーターのファイブフォース分析
  • 貿易分析
  • 関税と規制の分析
  • 特許分析
  • 主な会議とイベント
  • 主なステークホルダーと購入基準
  • 顧客のビジネスに影響を与える動向と混乱

第6章 分子品質管理市場：製品別

  • イントロダクション
  • 独立管理
  • 器具固有管理
    • ポリメラーゼ連鎖反応
    • DNAシーケンシング、NGS
    • その他の技術

第7章 分子品質管理市場：検体タイプ別

  • イントロダクション
  • 単一検体管理
  • 複数検体管理

第8章 分子品質管理市場：用途別

  • イントロダクション
  • 感染症診断
  • 腫瘍検査
  • 遺伝子検査
  • その他の用途

第9章 分子品質管理市場：エンドユーザー別

  • イントロダクション
  • 診断研究所
  • 病院
  • IVDメーカー・CRO
  • 学術・研究機関
  • その他のエンドユーザー

第10章 分子品質管理市場：地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
    • 北米：不況の影響
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • ロシア
    • その他の欧州
    • 欧州：不況の影響
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • その他のアジア太平洋
    • アジア太平洋：不況の影響
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他のラテンアメリカ
    • ラテンアメリカ：不況の影響
  • 中東とアフリカ

第11章 競合情勢

  • 概要
  • 主要企業が採用した戦略
  • 主な市場企業の収益シェア分析
  • 市場シェア分析
  • 主要企業の企業評価マトリックス（2022年）
  • スタートアップ/中小企業の企業評価マトリックス（2022年）
  • 企業フットプリント分析
  • 競合の状況と動向

第12章 企業プロファイル

  • 主要企業
    • LGC LIMITED
    • THERMO FISHER SCIENTIFIC, INC.
    • BIO-RAD LABORATORIES, INC.
    • MICROBIOLOGICS, INC.
    • ABBOTT LABORATORIES
    • F. HOFFMANN-LA ROCHE LTD.
    • ZEPTOMETRIX, LLC
    • QUIDELORTHO CORPORATION
    • QNOSTICS
    • MAINE MOLECULAR QUALITY CONTROLS, INC.
    • RANDOX LABORATORIES LTD.
    • DANAHER CORPORATION
    • BIO-TECHNE CORPORATION
    • FORTRESS DIAGNOSTICS
    • MICROBIX BIOSYSTEMS
    • GRIFOLS, S.A.
    • ANCHOR MOLECULAR
    • SPEEDX PTY. LTD.
    • SEEGENE INC.
    • HELENA LABORATORIES CORPORATION
  • その他の企業
    • SERO AS
    • VIRCELL, S.L.
    • STRECK LLC
    • SUN DIAGNOSTICS, LLC
    • MOLBIO DIAGNOSTICS PVT. LTD.

第13章 付録

目次
Product Code: MD 6900

The global molecular quality controls market is projected to reach USD 0.3 billion by 2028 from USD 0.2 billion in 2023, at a CAGR of 6.6% during the forecast period. Growth in this market is primarily driven by the increasing government funding for genomic projects, increasing demand for personalized medicines and declining costs of sequencing procedures, and increasing prevalence of infectious diseases, cancer, and genetic diseases. However, the additional costs involved in the quality control process and budget constraints in hospitals and laboratories, and the unfavorable reimbursement scenario for molecular tests are the major factors that are expected to restrain the growth of this market during the forecast period.

The independent controls segment has accounted for the biggest share of the market during the forecast period

By product, the molecular quality controls market is segmented into independent controls and instrument-specific controls. The independent controls segment accounted for the biggest share of the global molecular quality controls market in 2022. The increasing use of third-party independent quality controls is responsible for the large share of this segment.

The single-analyte controls has accounted for the biggest share of the market during the forecast period.

By analyte type, the molecular quality controls market is divided into single-analyte controls and multi-analyte controls. Single-analyte controls accounted for the biggest share of the molecular quality controls market in 2022. Factors such as the significant use of singleplex assays in hospitals, and low risk of cross-reactivity are responsible for the large share of this segment.

The infectious disease diagnostic segment accounted for the biggest share of the market in 2022

By application, the molecular quality controls market is divided into infectious disease diagnostics, genetic testing, oncology testing, and other applications (including neurology disease testing, , DNA fingerprinting, tissue typing, microbiology and cardiovascular disease testing). The infectious disease diagnostics segment accounted for the biggest share of the global molecular quality controls market in 2022. The significant increase in the prevalence of infectious diseases is responsible for the large share of this segment.

The diagnostic laboratories segment accounted for the biggest share of the market in 2022

By end users, the molecular quality controls market is segmented into academic & research institutes, diagnostic laboratories, IVD manufacturers & CROs, hospitals and other end users (home health agencies, blood banks, nursing homes, and local public health laboratories). The diagnostic laboratories segment accounted for the biggest share of the molecular quality controls market in 2022. The growing number of laboratory tests performed in diagnostic laboratories is responsible for the large share of this segment.

North America accounted for the largest share of the Molecular Quality Controls market in 2022

Based on region, the molecular quality controls market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the molecular quality controls market in 2022. The large share of this regional segment is mainly due to the developed healthcare system in the US and Canada, the presence of many leading molecular quality control product manufacturers, and easy accessibility to technologically advanced products in North America.

The break up of the profile of primary participants in the molecular Quality controls market:

  • By Company Type: Tier 1- 35%, Tier 2- 45%, and Tier 3-20%
  • By Designation: C-level Executives- 35%, Directors- 25% , and Others- 40%.
  • By Region: North America - 40%, Europe - 30%, APAC -20%, Latin America - 5%,Middle East & Africa-5%

Key players in the molecular quality controls market

The key players operating in the molecular quality controls market include Microbiologics, Inc. (US), Steck, Inc. (US), Bio-Rad Laboratories, Inc. (US), Anchor Molecular (US), Thermo Fisher Scientific, Inc. (US), Randox Laboratories Ltd. (UK), LGC Limited (UK), Abbott Laboratories (US), Fortress Diagnostics (UK), SERO AS (Norway), Anchor Molecular (US), Vircell S.L. (Spain), Ortho Clinical Diagnostics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Microbix Biosystems Inc. (Canada), Molbio Diagnostics Pvt. Ltd. (India), QuidelOrthoCorporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix, LLC (US), Qnostics (UK), Bio-Techne Corporation (US), Helena Laboratories Corporation (US), SpeeDx Pty. Ltd. (Australia), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain).

Research Coverage:

The report analyzes the molecular quality controls market and aims at estimating the market size and future growth potential of this market based on various segments such as product, analyte type, application, and end user. The report also includes a product portfolio matrix of various molecular quality controls products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

  • Analysis of key drivers (growing adoption of third-party quality controls, increasing investments in genomics, growing preference for personalized medicines, rising demand for external quality assessment support, and increasing prevalence of infectious diseases and cancer), restraints (high costs and budget constraints in clinical laboratories, and unfavorable reimbursement for molecular tests), opportunities (rising demand for multi-analyte controls, and growth opportunities in emerging countries), and challenges (changing regulatory framework)
  • Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new product launches in the global molecular quality controls market
  • Market Development: Comprehensive information on the lucrative emerging markets by product, analyte type, application, and end user.
  • Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global molecular quality controls market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global molecular quality controls market. This report also helps stakeholders understand the pulse of the molecular quality controls market and provides them information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
    • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • 1.5 STUDY LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES
  • 1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
  • 2.2 RESEARCH DESIGN
    • 2.2.1 SECONDARY RESEARCH
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY RESEARCH
    • FIGURE 2 PRIMARY SOURCES
      • 2.2.2.1 Key data from primary sources
    • FIGURE 3 INSIGHTS FROM INDUSTRY EXPERTS
      • 2.2.2.2 Breakdown of primaries
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION
    • FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 6 MOLECULAR QUALITY CONTROLS MARKET: REVENUE SHARE ANALYSIS
    • FIGURE 7 MARKET SIZE ESTIMATION: PARENT MARKET
    • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 9 MOLECULAR QUALITY CONTROLS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.5 MARKET SHARE ANALYSIS
  • 2.6 STUDY ASSUMPTIONS
  • 2.7 RISK ASSESSMENT
    • TABLE 2 MOLECULAR QUALITY CONTROLS MARKET: RISK ASSESSMENT ANALYSIS
  • 2.8 MARKET LIMITATIONS
    • 2.8.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.8.2 SCOPE-RELATED LIMITATIONS
  • 2.9 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 11 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 15 GEOGRAPHICAL SNAPSHOT OF MOLECULAR QUALITY CONTROLS MARKET

4 PREMIUM INSIGHTS

  • 4.1 MOLECULAR QUALITY CONTROLS MARKET OVERVIEW
    • FIGURE 16 RISING PREVALENCE OF INFECTIOUS DISEASES AND CANCER TO DRIVE MARKET
  • 4.2 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT
    • FIGURE 17 INSTRUMENT-SPECIFIC CONTROLS SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • 4.3 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION AND COUNTRY
    • FIGURE 18 INFECTIOUS DISEASE DIAGNOSTICS SEGMENT IN JAPAN ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
  • 4.4 MOLECULAR QUALITY CONTROLS MARKET: GEOGRAPHICAL MIX
    • FIGURE 19 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • 4.5 MOLECULAR QUALITY CONTROLS MARKET: DEVELOPED MARKETS VS. EMERGING MARKETS
    • FIGURE 20 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
    • FIGURE 21 MOLECULAR QUALITY CONTROLS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.1.1 DRIVERS
      • 5.1.1.1 Rising number of accredited clinical laboratories
    • FIGURE 22 NUMBER OF LABORATORIES WITH CLIA ACCREDITATION, BY ORGANIZATION (MAY 2023)
      • 5.1.1.2 Growing adoption of third-party quality controls
    • TABLE 3 THIRD-PARTY INDEPENDENT QUALITY CONTROLS OFFERED BY KEY COMPANIES
      • 5.1.1.3 Increasing investments in genomics
    • TABLE 4 GOVERNMENT FUNDING INITIATIVES FOR GENOMICS RESEARCH (2019-2022)
      • 5.1.1.4 Growing preference for personalized medicine
    • TABLE 5 US: NUMBER OF PERSONALIZED MEDICINES AVAILABLE (2008-2020)
    • FIGURE 23 FDA-APPROVED PERSONALIZED MEDICINES (2015-2022)
    • FIGURE 24 COST OF SEQUENCING PROCEDURES (2016-2021)
      • 5.1.1.5 Increasing prevalence of infectious diseases and cancer
    • FIGURE 25 GLOBAL CANCER INCIDENCE, 2018-2040 (MILLION)
      • 5.1.1.6 Rising demand for external quality assessment support
    • 5.1.2 RESTRAINTS
      • 5.1.2.1 Budgetary constraints in clinical laboratories
      • 5.1.2.2 Unfavorable reimbursements for molecular tests
    • 5.1.3 OPPORTUNITIES
      • 5.1.3.1 Rising demand for multi-analyte controls
      • 5.1.3.2 Growth opportunities in emerging markets
    • 5.1.4 CHALLENGES
      • 5.1.4.1 Stringent regulatory requirements for IVD products
  • 5.2 INDUSTRY TRENDS
    • 5.2.1 LYOPHILIZED/FREEZE-DRIED CONTROLS
    • TABLE 6 LYOPHILIZED OR FREEZE-DRIED QUALITY CONTROLS OFFERED BY KEY COMPANIES
  • 5.3 PRICING ANALYSIS
    • TABLE 7 PRICE RANGE FOR MOLECULAR QUALITY CONTROLS, BY TYPE (2022)
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 26 VALUE CHAIN ANALYSIS
  • 5.5 SUPPLY CHAIN ANALYSIS
    • FIGURE 27 SUPPLY CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS
    • FIGURE 28 MOLECULAR QUALITY CONTROLS MARKET: ECOSYSTEM MARKET MAP
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 8 MOLECULAR QUALITY CONTROLS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT OF NEW ENTRANTS
    • 5.7.2 THREAT OF SUBSTITUTES
    • 5.7.3 BARGAINING POWER OF BUYERS
    • 5.7.4 BARGAINING POWER OF SUPPLIERS
    • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 TRADE ANALYSIS
    • 5.8.1 TRADE ANALYSIS FOR DIAGNOSTIC & LABORATORY REAGENTS
      • 5.8.1.1 Import data for diagnostic & laboratory reagents, by country, 2018-2021 (USD million)
      • 5.8.1.2 Export data for diagnostic & laboratory reagents, by country, 2018-2021 (USD million)
  • 5.9 TARIFF AND REGULATORY ANALYSIS
    • 5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.9.2 REGULATORY ANALYSIS
      • 5.9.2.1 North America
        • 5.9.2.1.1 US
    • TABLE 10 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 11 US: CLASSIFICATION OF QUALITY CONTROL MATERIAL
    • TABLE 12 US: CLASSIFICATION, TIME, AND COMPLEXITY OF REGISTRATION
        • 5.9.2.1.2 Canada
    • TABLE 13 CANADA: CLASSIFICATION OF IVD PRODUCTS
    • TABLE 14 CANADA: CLASSIFICATION, TIME, AND COMPLEXITY OF REGISTRATION
      • 5.9.2.2 Europe
    • TABLE 15 EUROPE: ACCREDITATION BODIES FOR MEDICAL LABORATORIES
      • 5.9.2.3 Asia Pacific
        • 5.9.2.3.1 Japan
        • 5.9.2.3.2 China
        • 5.9.2.3.3 India
  • 5.10 PATENT ANALYSIS
    • 5.10.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    • FIGURE 29 MOLECULAR QUALITY CONTROLS MARKET: TOP PATENT OWNERS AND APPLICANTS (JANUARY 2011-JUNE 2023)
    • FIGURE 30 MOLECULAR QUALITY CONTROLS MARKET: TOP APPLICANT JURISDICTIONS (JANUARY 2011-JUNE 2023)
    • 5.10.2 PATENT PUBLICATION TRENDS
    • FIGURE 31 MOLECULAR QUALITY CONTROLS MARKET: PATENT ANALYSIS (JANUARY 2011-FEBRUARY 2023)
    • TABLE 16 MOLECULAR QUALITY CONTROLS MARKET: LIST OF PATENTS/PATENT APPLICATIONS (2020-2023)
  • 5.11 KEY CONFERENCES AND EVENTS
    • TABLE 17 MOLECULAR QUALITY CONTROLS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023-2024
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MOLECULAR QUALITY CONTROL PRODUCTS
    • TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MOLECULAR QUALITY CONTROL PRODUCTS (%)
    • 5.12.2 BUYING CRITERIA
    • FIGURE 33 KEY BUYING CRITERIA FOR MOLECULAR QUALITY CONTROL PRODUCTS
    • TABLE 19 KEY BUYING CRITERIA FOR MOLECULAR QUALITY CONTROL PRODUCTS
  • 5.13 TRENDS AND DISRUPTIONS AFFECTING CUSTOMERS' BUSINESSES
    • FIGURE 34 MOLECULAR QUALITY CONTROLS MARKET: REVENUE SHIFT

6 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 20 QUALITY CONTROLS FOR MOLECULAR DIAGNOSTICS OFFERED BY KEY MARKET PLAYERS
    • TABLE 21 MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 6.2 INDEPENDENT CONTROLS
    • 6.2.1 MINIMIZED LOT CROSSOVERS FOR LABORATORIES AND LOW OPERATION COSTS TO DRIVE MARKET
    • TABLE 22 INDEPENDENT MOLECULAR QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
    • TABLE 23 INDEPENDENT MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 INSTRUMENT-SPECIFIC CONTROLS
    • TABLE 24 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS
    • TABLE 25 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 26 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 6.3.1 POLYMERASE CHAIN REACTION
      • 6.3.1.1 Rising applications in proteomics and genomics to propel market
    • TABLE 27 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET FOR PCR, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.2 DNA SEQUENCING AND NGS
      • 6.3.2.1 Increasing advancements in sequencing technologies to drive market
    • TABLE 28 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET FOR DNA SEQUENCING & NGS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.3 OTHER TECHNOLOGIES
    • TABLE 29 INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)

7 MOLECULAR QUALITY CONTROL MARKET, BY ANALYTE TYPE

  • 7.1 INTRODUCTION
    • TABLE 30 MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
  • 7.2 SINGLE-ANALYTE CONTROLS
    • 7.2.1 RISING ADOPTION OF SINGLEPLEX ASSAYS IN HOSPITALS TO SUPPORT MARKET GROWTH
    • TABLE 31 SINGLE-ANALYTE CONTROLS OFFERED BY KEY MARKET PLAYERS
    • TABLE 32 SINGLE-ANALYTE MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 MULTI-ANALYTE CONTROLS
    • 7.3.1 GROWING PREFERENCE FOR COST-EFFECTIVE CONTROLS TO DRIVE MARKET
    • TABLE 33 MULTI-ANALYTE CONTROLS OFFERED BY KEY MARKET PLAYERS
    • TABLE 34 MULTI-ANALYTE MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

8 MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 35 MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.2 INFECTIOUS DISEASE DIAGNOSTICS
    • 8.2.1 RISING INCIDENCE OF INFLUENZA, TB, AND HIV TO DRIVE MARKET
    • TABLE 36 NUMBER OF COVID-19 CASES, BY COUNTRY (FEBRUARY 2023)
    • TABLE 37 MOLECULAR QUALITY CONTROLS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 ONCOLOGY TESTING
    • 8.3.1 GROWING FOCUS ON PERSONALIZED MEDICINE TO PROPEL MARKET
    • TABLE 38 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
    • TABLE 39 MOLECULAR QUALITY CONTROLS MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 GENETIC TESTING
    • 8.4.1 ABILITY TO DIAGNOSE RARE DISEASES TO SUPPORT MARKET GROWTH
    • TABLE 40 MOLECULAR QUALITY CONTROLS MARKET FOR GENETIC TESTING, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.5 OTHER APPLICATIONS
    • TABLE 41 MOLECULAR QUALITY CONTROLS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

9 MOLECULAR QUALITY CONTROLS MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 42 MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2 DIAGNOSTIC LABORATORIES
    • 9.2.1 INCREASING NUMBER OF ACCREDITED DIAGNOSTIC LABORATORIES TO DRIVE MARKET
    • TABLE 43 MOLECULAR QUALITY CONTROLS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 HOSPITALS
    • 9.3.1 ABILITY TO CONDUCT LARGE VOLUME OF DIAGNOSTIC PROCEDURES TO PROPEL MARKET
    • TABLE 44 MOLECULAR QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.4 IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS
    • 9.4.1 ADVANCEMENTS IN MOLECULAR TECHNOLOGIES TO SUPPORT MARKET GROWTH
    • TABLE 45 MOLECULAR QUALITY CONTROLS MARKET FOR IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.5 ACADEMIC & RESEARCH INSTITUTES
    • 9.5.1 RISING FOCUS ON ACCURATE RESEARCH RESULTS TO DRIVE MARKET
    • TABLE 46 MOLECULAR QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.6 OTHER END USERS
    • TABLE 47 MOLECULAR QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

10 MOLECULAR QUALITY CONTROLS MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 48 MOLECULAR QUALITY CONTROLS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 35 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
    • TABLE 49 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 50 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 51 NORTH AMERICA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 52 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 53 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 54 NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Growing number of accredited clinical laboratories to drive market
    • FIGURE 36 US: NUMBER OF LABORATORIES WITH CLIA ACCREDITATION, BY ORGANIZATION (MAY 2023)
    • TABLE 55 US: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 56 US: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 57 US: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 58 US: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 59 US: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Rising funding investments for genomic research to propel market
    • TABLE 60 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 61 CANADA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 62 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 63 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 64 CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.3 NORTH AMERICA: RECESSION IMPACT
  • 10.3 EUROPE
    • TABLE 65 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 66 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 67 EUROPE: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 68 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 69 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 70 EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Rising volume of diagnostic tests in clinical settings to drive market
    • TABLE 71 GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 72 GERMANY: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 73 GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 74 GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 75 GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Growth in life sciences industry to propel market
    • TABLE 76 UK: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 77 UK: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 78 UK: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 79 UK: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 80 UK: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Rising prevalence of cancer and endocrine disorders to support market growth
    • TABLE 81 FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 82 FRANCE: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 83 FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 84 FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 85 FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Rising incidence of age-associated chronic ailments to support market growth
    • TABLE 86 ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 87 ITALY: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 88 ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 89 ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 90 ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Increasing demand for prenatal and genetic testing to support market growth
    • TABLE 91 SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 92 SPAIN: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 93 SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 94 SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 95 SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.6 RUSSIA
      • 10.3.6.1 Growing acceptance of molecular diagnostics-based personalized medicine to propel market
    • TABLE 96 RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 97 RUSSIA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 98 RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 99 RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 100 RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.7 REST OF EUROPE
    • TABLE 101 REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 102 REST OF EUROPE: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 103 REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 104 REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 105 REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.8 EUROPE: RECESSION IMPACT
  • 10.4 ASIA PACIFIC
    • FIGURE 37 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
    • TABLE 106 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 107 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 108 ASIA PACIFIC: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 109 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 110 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 111 ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Established healthcare system and rising demand for high-quality IVD tests to drive market
    • TABLE 112 JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 113 JAPAN: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 114 JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 115 JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 116 JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Rising R&D investments for advanced molecular tests to drive market
    • TABLE 117 CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 118 CHINA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 119 CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 120 CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 121 CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Rising need to secure NABL accreditations to support market growth
    • FIGURE 38 INDIA: INCREASING NUMBER OF LABORATORIES WITH NABL ACCREDITATIONS (2012-2020)
    • TABLE 122 INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 123 INDIA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 124 INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 125 INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 126 INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.4 AUSTRALIA
      • 10.4.4.1 High prevalence of infectious diseases to fuel market
    • TABLE 127 AUSTRALIA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 128 AUSTRALIA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 129 AUSTRALIA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 130 AUSTRALIA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 131 AUSTRALIA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.5 REST OF ASIA PACIFIC
    • TABLE 132 REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 133 REST OF ASIA PACIFIC: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 134 REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 135 REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 136 REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.6 ASIA PACIFIC: RECESSION IMPACT
  • 10.5 LATIN AMERICA
    • TABLE 137 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 138 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 139 LATIN AMERICA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 140 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 141 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 142 LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, ' 2021-2028 (USD MILLION)
    • 10.5.1 BRAZIL
      • 10.5.1.1 Improving healthcare infrastructure to support market growth
    • TABLE 143 BRAZIL: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 144 BRAZIL: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 145 BRAZIL: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 146 BRAZIL: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 147 BRAZIL: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.2 MEXICO
      • 10.5.2.1 Improving accessibility and affordability of healthcare services to support market growth
    • TABLE 148 MEXICO: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 149 MEXICO: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 150 MEXICO: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 151 MEXICO: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 152 MEXICO: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.3 REST OF LATIN AMERICA
    • TABLE 153 REST OF LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 154 REST OF LATIN AMERICA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 155 REST OF LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 156 REST OF LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 157 REST OF LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.4 LATIN AMERICA: RECESSION IMPACT
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 GOVERNMENT INITIATIVES TO IMPROVE HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
    • 10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
    • TABLE 158 MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
    • TABLE 159 MIDDLE EAST & AFRICA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 160 MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021-2028 (USD MILLION)
    • TABLE 161 MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 162 MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021-2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 STRATEGIES ADOPTED BY KEY PLAYERS
  • 11.3 REVENUE SHARE ANALYSIS OF LEADING MARKET PLAYERS
    • FIGURE 39 MOLECULAR QUALITY CONTROLS MARKET: REVENUE SHARE ANALYSIS OF LEADING PLAYERS
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 40 MOLECULAR QUALITY CONTROLS MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)
    • TABLE 163 MOLECULAR QUALITY CONTROLS MARKET: INTENSITY OF COMPETITIVE RIVALRY
  • 11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 41 MOLECULAR QUALITY CONTROLS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
  • 11.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
    • FIGURE 42 MOLECULAR QUALITY CONTROLS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
  • 11.7 COMPANY FOOTPRINT ANALYSIS
    • TABLE 164 MOLECULAR QUALITY CONTROLS MARKET: COMPANY FOOTPRINT ANALYSIS
    • TABLE 165 MOLECULAR QUALITY CONTROLS MARKET: ANALYTE TYPE FOOTPRINT ANALYSIS
    • TABLE 166 MOLECULAR QUALITY CONTROLS MARKET: APPLICATION FOOTPRINT ANALYSIS
    • TABLE 167 MOLECULAR QUALITY CONTROLS MARKET: REGIONAL FOOTPRINT ANALYSIS
    • TABLE 168 MOLECULAR QUALITY CONTROLS MARKET: END USER FOOTPRINT ANALYSIS
  • 11.8 COMPETITIVE SITUATION AND TRENDS
    • 11.8.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 169 PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-JUNE 2023)
    • 11.8.2 DEALS
    • TABLE 170 DEALS (JANUARY 2020-JUNE 2023)
    • 11.8.3 OTHER DEVELOPMENTS
    • TABLE 171 OTHER DEVELOPMENTS (JANUARY 2020-JUNE 2023)

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View)**
    • 12.1.1 LGC LIMITED
    • TABLE 172 LGC LIMITED: BUSINESS OVERVIEW
    • FIGURE 43 LCG LIMITED: COMPANY SNAPSHOT (2022)
    • 12.1.2 THERMO FISHER SCIENTIFIC, INC.
    • TABLE 173 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
    • FIGURE 44 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
    • 12.1.3 BIO-RAD LABORATORIES, INC.
    • TABLE 174 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 45 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
    • 12.1.4 MICROBIOLOGICS, INC.
    • TABLE 175 MICROBIOLOGICS, INC.: BUSINESS OVERVIEW
    • 12.1.5 ABBOTT LABORATORIES
    • TABLE 176 ABBOTT LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 46 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
    • 12.1.6 F. HOFFMANN-LA ROCHE LTD.
    • TABLE 177 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
    • FIGURE 47 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
    • 12.1.7 ZEPTOMETRIX, LLC
    • TABLE 178 ZEPTOMETRIX, LLC: BUSINESS OVERVIEW
    • 12.1.8 QUIDELORTHO CORPORATION
    • TABLE 179 QUIDELORTHO CORPORATION: BUSINESS OVERVIEW
    • FIGURE 48 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2022)
    • 12.1.9 QNOSTICS
    • TABLE 180 QNOSTICS: BUSINESS OVERVIEW
    • 12.1.10 MAINE MOLECULAR QUALITY CONTROLS, INC.
    • TABLE 181 MAINE MOLECULAR QUALITY CONTROLS, INC.: BUSINESS OVERVIEW
    • 12.1.11 RANDOX LABORATORIES LTD.
    • TABLE 182 RANDOX LABORATORIES LTD.: BUSINESS OVERVIEW
    • 12.1.12 DANAHER CORPORATION
    • TABLE 183 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 49 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
    • 12.1.13 BIO-TECHNE CORPORATION
    • TABLE 184 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW
    • FIGURE 50 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2022)
    • 12.1.14 FORTRESS DIAGNOSTICS
    • TABLE 185 FORTRESS DIAGNOSTICS: BUSINESS OVERVIEW
    • 12.1.15 MICROBIX BIOSYSTEMS
    • TABLE 186 MICROBIX BIOSYSTEMS: BUSINESS OVERVIEW
    • FIGURE 51 MICROBIX BIOSYSTEMS: COMPANY SNAPSHOT (2022)
    • 12.1.16 GRIFOLS, S.A.
    • TABLE 187 GRIFOLS, S.A.: BUSINESS OVERVIEW
    • FIGURE 52 GRIFOLS, S.A.: COMPANY SNAPSHOT (2022)
    • 12.1.17 ANCHOR MOLECULAR
    • TABLE 188 ANCHOR MOLECULAR: BUSINESS OVERVIEW
    • 12.1.18 SPEEDX PTY. LTD.
    • TABLE 189 SPEEDX PTY. LTD.: BUSINESS OVERVIEW
    • 12.1.19 SEEGENE INC.
    • TABLE 190 SEEGENE INC.: BUSINESS OVERVIEW
    • FIGURE 53 SEEGENE INC: COMPANY SNAPSHOT (2022)
    • 12.1.20 HELENA LABORATORIES CORPORATION
    • TABLE 191 HELENA LABORATORIES CORPORATION: BUSINESS OVERVIEW
  • 12.2 OTHER PLAYERS
    • 12.2.1 SERO AS
    • TABLE 192 SERO AS: BUSINESS OVERVIEW
    • 12.2.2 VIRCELL, S.L.
    • TABLE 193 VIRCELL, S.L.: BUSINESS OVERVIEW
    • 12.2.3 STRECK LLC
    • TABLE 194 STRECK LLC.: BUSINESS OVERVIEW
    • 12.2.4 SUN DIAGNOSTICS, LLC
    • TABLE 195 SUN DIAGNOSTICS, LLC: BUSINESS OVERVIEW
    • 12.2.5 MOLBIO DIAGNOSTICS PVT. LTD.
    • TABLE 196 MOLBIO DIAGNOSTICS PVT. LTD.: BUSINESS OVERVIEW
  • *Details on Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS